Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement

BACKGROUND: Outcomes-based agreements (OBA) are performance-based risk-sharing agreements between manufacturers and payers which provide the opportunity for collection and evaluation of real-world outcomes to supplement clinical trials. OBJECTIVES: To describe an OBA comparing ticagrelor to clopidog...

Descripción completa

Detalles Bibliográficos
Autores principales: Peasah, Samuel K., Huang, Yan, Venditto, John, Brekosky, Robert, Belletti, Daniel, Campbell, Vanessa, Manolis, Chronis, Good, Chester B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618484/
https://www.ncbi.nlm.nih.gov/pubmed/37920750
http://dx.doi.org/10.1016/j.rcsop.2023.100347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618484/
https://www.ncbi.nlm.nih.gov/pubmed/37920750
http://dx.doi.org/10.1016/j.rcsop.2023.100347

Ejemplares similares